FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3146562435> ?p ?o ?g. }

• W3146562435 abstract "Androgen receptor (AR) plays a critical function in driving prostate cancer (PCa) development and androgen deprivation therapy (ADT) is standard of care in treating PCa patients. Although patients generally response well, the cancer eventually relapse and progress to the castration-resistant stage of PCa (called CRPC), which can be further treated with more aggressive ADT. However, the tumors still develop resistance within a year and restored AR activity is found in the majority of relapsed tumors, indicating a pressing need for developing novel AR-targeted therapies. In PCa cells, AR activity is dependent on the chromatin binding of the pioneer factor, FOXA1. In particular, FOXA1 recognizes the H3K4me1,2 marked enhancers and its binding opens the chromatin for subsequent AR recruitment. Although the role of FOXA1 on AR signaling has been intensively studied, the mechanisms regulating FOXA1 binding to chromatin remain elusive. LSD1/KDM1A was initially identified as a transcription repressor through demethylation of H3K4me1,2. In contrast to its well-established corepressor function, LSD1 has been found to coactivate several transcription factors including AR. This AR coactivator function has been attributed to the phosphorylation of histone 3 on threonine 6 and threonine 11, which may switch LSD1 substrate specificity from H3K4me1,2 to the repressive mark H3K9me1,2. However, we have recently reported that the H3K4 demethylase activity of LSD1 persists at AR-regulated enhancer sites, including sites marked by H3T6ph, arguing against the coactivator function of LSD1 being generally controlled by this mechanism. Importantly, we have shown in a recent study that LSD1 associates with FOXA1 and active enhancer markers, and that LSD1 silencing impaired FOXA1 binding at AR-regulated enhancers, suggesting a role of LSD1 in regulating enhancer availability to AR. In the current study, we found that LSD1 inhibition globally disrupts FOXA1 chromatin binding prior to androgen stimulation and thus impairs further AR recruitment, resulting in the global inhibition of AR transcriptome. Using immunoprecipitation and mass-spectrometry assays, we discovered that LSD1 maintains FOXA1 binding by demethylating lysine K270, adjacent to its DNA binding domain. We further found that the expression of a methylation-deficient FOXA1 mutant (K270R) stabilizes AR chromatin binding and allows PCa cells resistant to enzalutamide treatment. Using a clinical tested LSD1 inhibitor, we have shown in vivothat LSD1 inhibition dramatically decreases PCa growth alone and in synergy with enzalutamide in AR/AR variants-positive CRPC models. These findings provide fundamental new insights into FOXA1, LSD1, and mechanisms that regulate the activity of AR in PCa cells. As LSD1 inhibitors are moving into the clinic, these new insights into LSD1 function strongly support LSD1 as a therapeutic target in CRPC. Citation Format: Shuai Gao, Sujun Chen, Dong Han, Wanting Han, Jude N. Owiredu, Steven P. Balk, Housheng H. He, Changmeng Cai. FOXA1 chromatin binding is regulated by LSD1-mediated methylation in prostate cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 923." @default.
• W3146562435 created "2021-04-13" @default.
• W3146562435 creator A5000986972 @default.
• W3146562435 creator A5028346601 @default.
• W3146562435 creator A5050721657 @default.
• W3146562435 creator A5050848129 @default.
• W3146562435 creator A5067278383 @default.
• W3146562435 creator A5086472811 @default.
• W3146562435 creator A5087350413 @default.
• W3146562435 date "2019-07-01" @default.
• W3146562435 modified "2023-09-23" @default.
• W3146562435 title "Abstract 923: FOXA1 chromatin binding is regulated by LSD1-mediated methylation in prostate cancer cells" @default.
• W3146562435 doi "https://doi.org/10.1158/1538-7445.am2019-923" @default.
• W3146562435 hasPublicationYear "2019" @default.
• W3146562435 type Work @default.
• W3146562435 sameAs 3146562435 @default.
• W3146562435 citedByCount "0" @default.
• W3146562435 crossrefType "proceedings-article" @default.
• W3146562435 hasAuthorship W3146562435A5000986972 @default.
• W3146562435 hasAuthorship W3146562435A5028346601 @default.
• W3146562435 hasAuthorship W3146562435A5050721657 @default.
• W3146562435 hasAuthorship W3146562435A5050848129 @default.
• W3146562435 hasAuthorship W3146562435A5067278383 @default.
• W3146562435 hasAuthorship W3146562435A5086472811 @default.
• W3146562435 hasAuthorship W3146562435A5087350413 @default.
• W3146562435 hasConcept C104317684 @default.
• W3146562435 hasConcept C111936080 @default.
• W3146562435 hasConcept C121608353 @default.
• W3146562435 hasConcept C126322002 @default.
• W3146562435 hasConcept C130321593 @default.
• W3146562435 hasConcept C154456304 @default.
• W3146562435 hasConcept C185592680 @default.
• W3146562435 hasConcept C2777899217 @default.
• W3146562435 hasConcept C2780192828 @default.
• W3146562435 hasConcept C502942594 @default.
• W3146562435 hasConcept C530470458 @default.
• W3146562435 hasConcept C552990157 @default.
• W3146562435 hasConcept C55493867 @default.
• W3146562435 hasConcept C61367390 @default.
• W3146562435 hasConcept C64927066 @default.
• W3146562435 hasConcept C71924100 @default.
• W3146562435 hasConcept C77445288 @default.
• W3146562435 hasConcept C83640560 @default.
• W3146562435 hasConcept C86339819 @default.
• W3146562435 hasConceptScore W3146562435C104317684 @default.
• W3146562435 hasConceptScore W3146562435C111936080 @default.
• W3146562435 hasConceptScore W3146562435C121608353 @default.
• W3146562435 hasConceptScore W3146562435C126322002 @default.
• W3146562435 hasConceptScore W3146562435C130321593 @default.
• W3146562435 hasConceptScore W3146562435C154456304 @default.
• W3146562435 hasConceptScore W3146562435C185592680 @default.
• W3146562435 hasConceptScore W3146562435C2777899217 @default.
• W3146562435 hasConceptScore W3146562435C2780192828 @default.
• W3146562435 hasConceptScore W3146562435C502942594 @default.
• W3146562435 hasConceptScore W3146562435C530470458 @default.
• W3146562435 hasConceptScore W3146562435C552990157 @default.
• W3146562435 hasConceptScore W3146562435C55493867 @default.
• W3146562435 hasConceptScore W3146562435C61367390 @default.
• W3146562435 hasConceptScore W3146562435C64927066 @default.
• W3146562435 hasConceptScore W3146562435C71924100 @default.
• W3146562435 hasConceptScore W3146562435C77445288 @default.
• W3146562435 hasConceptScore W3146562435C83640560 @default.
• W3146562435 hasConceptScore W3146562435C86339819 @default.
• W3146562435 hasLocation W31465624351 @default.
• W3146562435 hasOpenAccess W3146562435 @default.
• W3146562435 hasPrimaryLocation W31465624351 @default.
• W3146562435 hasRelatedWork W1210100457 @default.
• W3146562435 hasRelatedWork W2045597373 @default.
• W3146562435 hasRelatedWork W2061639397 @default.
• W3146562435 hasRelatedWork W2067787704 @default.
• W3146562435 hasRelatedWork W2079886656 @default.
• W3146562435 hasRelatedWork W2114831067 @default.
• W3146562435 hasRelatedWork W2341215534 @default.
• W3146562435 hasRelatedWork W2525423783 @default.
• W3146562435 hasRelatedWork W2565270005 @default.
• W3146562435 hasRelatedWork W2741828858 @default.
• W3146562435 hasRelatedWork W2953588497 @default.
• W3146562435 hasRelatedWork W2953702378 @default.
• W3146562435 hasRelatedWork W2954616154 @default.
• W3146562435 hasRelatedWork W2962717375 @default.
• W3146562435 hasRelatedWork W2991056251 @default.
• W3146562435 hasRelatedWork W3017681208 @default.
• W3146562435 hasRelatedWork W3081825656 @default.
• W3146562435 hasRelatedWork W3082264507 @default.
• W3146562435 hasRelatedWork W3091642685 @default.
• W3146562435 hasRelatedWork W3178600917 @default.
• W3146562435 isParatext "false" @default.
• W3146562435 isRetracted "false" @default.
• W3146562435 magId "3146562435" @default.
• W3146562435 workType "article" @default.